Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus - induced demyelinating disease by modifying Nrf2-Keap1 pathway.
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate.
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Zebrafish: A new vertebrate model for visualizing myelination in vivo.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy.
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Sox10 Expression in Goldfish Retina and Optic Nerve Head in Controls and after the Application of Two Different Lesion Paradigms.
Radiation-induced brain injury: low-hanging fruit for neuroregeneration.
Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon.
Will the real multiple sclerosis please stand up?

Pages